<DOC>
	<DOCNO>NCT00232765</DOCNO>
	<brief_summary>The main objective study assess safety effectiveness sirolimus-coated Bx VELOCITYTM stent reduce target vessel failure de novo native coronary artery lesion compare uncoated Bx VELOCITYTM balloon-expandable stent . Both stent mount Raptor√¢ over-the-wire ( OTW ) Stent Delivery System .</brief_summary>
	<brief_title>Study Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent Treatment de Novo Native Coronary Artery Lesions ( SIRIUS )</brief_title>
	<detailed_description>This multicenter ( 55 site ) , prospective , 2-arm randomize , double-blind study design ass safety effectiveness sirolimus-coated Bx VELOCITYTM stent compare uncoated Bx VELOCITYTM stent . A total 1100 patient enter study randomize 1:1 basis . Patients de novo native coronary artery lesion &gt; /=15mm &lt; /=30mm length &gt; /=2.50mm &lt; /=3.5mm diameter visual estimate meet eligibility criterion either randomize sirolimus-coated Bx VELOCITYTM stent uncoated Bx VELOCITYTM stent . Patients follow 30 day , 3 , 6 , 9 12 month , 2 , 3 , 4 , 5 , 6 , 7 , 8 year post-procedure , approximately 850 patient repeat angiography 8 month . A subset approximately 17 center participate intravascular ultrasound ( IVUS ) sub study , patient center enrol sub study . Additionally , data collect medical economic analysis . These data include cost associated index hospitalization length stay , rehospitalizations 12-month follow-up period . This single lesion treatment study . Patients intervention lesion within 30 day study procedure intervention plan index procedure exclude . It anticipate total length study 101 month : 5 month complete patient enrollment 8 year follow-up .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Male nonpregnant female patient minimum 18 year age 2 . Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS I , II , III , IV ) OR unstable angina pectoris ( Braunwald Classification B &amp; C , III ) OR patient document silent ischemia ; 3 . Target lesion 2.50mm 3.5mm diameter ( visual estimate ) ; 4 . Target lesion 15mm 30mm length ( visual estimate ) ; 5 . Target lesion stenosis &gt; 50 % &lt; 100 % ( visual estimate ) ; 1 . Patient experience Qwave nonQwave myocardial infarction document total CK &gt; 2 time normal within precede 24 hour CK CKMB enzymes remain normal time treatment ; 2 . Has unstable angina classified Braunwald III B C , peri infarction ; 3 . Documented Left ventricular ejection fraction 25 % ; 4 . Impaired renal function ( creatinine &gt; 3.0 mg/dl ) time treatment ; 5 . Target lesion involve bifurcation include diseased side branch 2.5mm diameter ( either stenosis main vessel major branch stenosis major branch ) would require treatment ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>